Ocular surface adverse events of systemic epidermal growth factor receptor inhibitors (EGFRi): A prospective trial. [electronic resource]
Producer: 20190412Description: 955-962 p. digitalISSN:- 1773-0597
- Adenocarcinoma -- drug therapy
- Administration, Oral
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Camptothecin -- analogs & derivatives
- Case-Control Studies
- Colorectal Neoplasms -- drug therapy
- Cornea -- diagnostic imaging
- Dry Eye Syndromes -- chemically induced
- ErbB Receptors -- antagonists & inhibitors
- Female
- Fluorouracil -- therapeutic use
- Humans
- Leucovorin -- therapeutic use
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Organoplatinum Compounds -- therapeutic use
- Prospective Studies
- Protein Kinase Inhibitors -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.